New targets in tumor angiogenesis to block tumor re-growth and therapeutic resistance 

Bassani, Nicklas (Date of defense: 2017-12-15)

Antiangiogenic drugs are used clinically for treatment of different types of cancers and in the case of renal cell carcinoma (RCC) are now standard first-line treatments (Rini, 2009). Nevertheless, these agents mainly serve ...